Innovative Solutions

Data Science

Datalore Cube is a self-service clinical-molecular data
platform that enables biopharma companies to identify
and analyze cohorts of interest for drug development.



For Biopharma Partners

Innovative Solutions

Real World Study



Partner with biopharma to accelerate data-driven
therapy development with real-world evidence

Discover novel biomarkers: Leverage real-world multimodal data and bioinformatics expertise to identify new biomarkers including FGFR/KRAS/MET/TMB, ongoing tumor monitoring, and new diagnostic procedures.
Collaborate with international pharmaceutical companies to discover new treatment targets, diagnostic procedures, and to commercialize these technologies.

Asian pan-cancer clinical
and genomic database

Landscape of somatic alterations in large-scale solid tumors
from an Asian population

You can obtain from
OrigiMed Chinese
Real-World Data

Prevalence of specific patient populations in China

Utilizing RWD to uncover the proportion and total count of patients with genetic variations, biomarkers, and specific clinical characteristics in China.
Comparative analysis of subgroups

Revealing the clinical and molecular characteristics, treatment profiles, and outcomes (such as rwTTNT, rwOS , etc.) across different subgroups.
Exploration of novel biomarkers

For example investigating the associations and exclusivity between new targets
and known molecular biomarkers, as well as clinical and immune
microenvironment characteristics, to inform the design of future clinical trials.
Hypothesis generation and validation

Identification of key factors influencing patient prognosis or response, indicating novel therapeutic options for specific patients.
Real-world evidence

The utilization of high-quality structured real-world data enables direct translation into robust real-world evidence, thereby supporting single-arm clinical trials and the exploration of new.

Geographical coverage

Tumor type coverage